Company intelligence / Profile preview

Aveva Drug Delivery Systems

Miramar, Florida, United States

Ownership: Private
Employees: ~177
Development stage: Other

Overview

Aveva Drug Delivery Systems operates as a commercial contract developer and manufacturer of proprietary and generic transdermal patches, with multiple approved products including fentanyl, clonidine, and nicotine patches and ongoing collaborations with pharmaceutical partners for lifecycle management and new chemical entities.[3][7][8]

Therapeutic areas: CardiovascularNeurologyDermatologyGastroenterologyPsychiatry
Modalities: Small moleculeDeviceTransdermal patchTransdermal drug delivery system
Industry: Biotech

Drug pipeline

1 asset

Lidocaine and Liquid Paraffin

Unknown

Partnerships

Multiple pharmaceutical partners for proprietary and generic transdermal product development and lifecycle management (not individually named).[3][7]

Beyond the preview

Go deeper on Aveva Drug Delivery Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aveva Drug Delivery Systems.

Explore the full profile